Table 5.
GSTπ levels in urine.
| Group | GST π in urine [ng/mg cr.] | |||
|---|---|---|---|---|
| Mean | SD | Me | p-value | |
| BC | 15.81 | 21.08 | 8.68 | p=0.0005 BC vs C |
| C | 4.62 | 3.43 | 3.48 | |
|
| ||||
| NMIBC | 17.17 | 23.23 | 8.57 | p=0.9606NMIBC vs MIBC |
| MIBC | 10.19 | 5.34 | 9.12 | |
|
| ||||
| LG | 12.80 | 16.99 | 7.91 | p=0.1281LG vs HG |
| HG | 20.05 | 25.75 | 13.71 | |
|
| ||||
| Non-smoking patients | 18.23 | 37.58 | 7.79 | p>0.05non-smoking vs smoking |
| Smoking patients | 15.22 | 15.65 | 8.85 | |
UPIIIa: uroplakin IIIa; C: control group; BC: patients group; NMIBC: nonmuscle invasive BC; MIBC: muscle invasive BC; LG: low grade; HG: high grade; SD: standard deviation; p: statistically significant difference; Me: median